Products for Research Use Only
RegisterLogin

Tamgiblimab

CAT: 0804-HY-P99508-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99508-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tamgiblimab (IBI939) is a fully human monoclonal antibody targeting T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT) . Tamgiblimab has anticancer effects[1].
CAS Number
2411914-36-6
Product Name Alternative
IBI939
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tamgiblimab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Tamgiblimab]
Molecular Weight
(144.34 kDa)
References & Citations
[1]Y. Cheng, et al. 77P A study to evaluate the safety, tolerability and efficacy of IBI939 in combination with sintilimab in patients with previously untreated locally advanced unresectable or metastatic PD-L1-selected non-small cell lung cancer (NSCLC) . Immuno-Oncology and Technology. DECEMBER 01, 2022.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Alternative Products

CatalogName
MBS5822702Tamgiblimab
GTR18333557-01Tamgiblimab Antibody
WA3607Research Grade Tamgiblimab
ICH5279-20mgTamgiblimab Biosimilar - Research Grade
A138211Tamgiblimab Biosimilar (Monoclonal, IgG4)
GTR18780776-01(Tamgiblimab) Biosimilar Reference Antibody
GTR18697305-01Tamgiblimab Human Monoclonal Antibody
MBS1881753-01Anti-TIGIT (tamgiblimab biosimilar) mAb
RA0737-01Tamgiblimab (Biosimilar Reference Antibody) (TIGIT)
A135538Tamgiblimab Biosimilar (Monoclonal, IgG4-kappa)

Popular Products